Annovis Bio to Showcase New Alzheimer’s Study Findings at AAIC 2024CreativeJune 18, 2024June 18, 2024 June 18, 2024June 18, 2024 Annovis Bio (NYSE: ANVS), a late-stage biotechnology company specializing in the development of innovative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s...
